全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Multiple Cutaneous Angiosarcomas after Breast Conserving Surgery and Bilateral Adjuvant Radiotherapy: An Unusual Case and Review of the Literature

DOI: 10.1155/2014/413030

Full-Text   Cite this paper   Add to My Lib

Abstract:

Breast angiosarcomas (BAs) are rare but serious events that may arise after radiation exposure. Disease outcome is poor, with high risk of local and distant failure. Recurrences are frequent also after resection with negative margins. The spectrum of vascular proliferations associated with radiotherapy in the setting of breast cancer has expanded, including radiation-associated atypical vascular lesions (AVLs) of the breast skin as a rare, but well-recognized, entity. Although pursuing a benign behavior, AVLs have been regarded as possible precursors of postradiation BAs. We report an unusual case of a 71-year-old woman affected by well-differentiated bilateral cutaneous BA, diagnosed 1.9 years after adjuvant RT for synchronous bilateral breast cancer. Whole-life clinical followup is of crucial importance in breast cancer patients. 1. Introduction Angiosarcomas (ASs) are rare malignant tumors that arise from endothelial cells lining vascular channels [1, 2]. They account for less than 1% of all soft tissue sarcomas and occur in all organs of the body. Approximately 8% of ASs arise in the breast [3]. Primary breast angiosarcomas (BAs) most commonly affect women aged 20 to 40 years without a recognized associated factor [4]. Secondary BAs are usually found in older women at the site of radiotherapy (RT) for breast cancer (BC). They typically involve the dermis and present with skin changes that can easily be misinterpreted even with benign conditions such infection [5]. Neoplastic events attributed to RT in the context of BC are rare. Such occurrences are largely restricted to possible secondary lung and BC, osteosarcomas, malignant fibrous histiocytomas, and fibrosarcomas [5–8]. Postradiation BAs are defined by three characteristics: location in the field of radiation, latency of years after RT, and histologic distinction from the primary neoplasm [9]. The latency period, or interval between RT and the diagnosis of BA, ranges from 3 to 12 years, with most tumors occurring within 6 years after RT [10]. In recent years, the spectrum of vascular proliferations associated with RT in the setting of BC has expanded, including radiation-associated atypical vascular lesions (AVLs) of the breast skin as a rare, but well-recognized, entity [9, 11]. Since clinic and histologic overlap with well-differentiated BA is likely, AVLs represent a diagnostic and therapeutic challenge. Moreover, although pursuing a benign behavior, AVLs have been regarded as possible precursors of postradiation BAs [12]. We report an unusual case of a 71-year-old woman affected by

References

[1]  P. Rosen, “Sarcoma,” in Rosen’s Breast Pathology, P. P. Rosen, Ed., pp. 813–861, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2001.
[2]  J. M. Bardwil, E. E. Mocega, J. J. Butler, and D. J. Russin, “Angiosarcomas of the head and neck region,” The American Journal of Surgery, vol. 116, no. 4, pp. 548–553, 1968.
[3]  A. L. Folpe and A. M. Gowen, Malignant Vascular Tumors. Soft Tissue Tumors, Mosby, St. Louis, Miss, USA, 1995.
[4]  A. F. Nascimento, C. P. Raut, and C. D. M. Fletcher, “Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic,” American Journal of Surgical Pathology, vol. 32, no. 12, pp. 1896–1904, 2008.
[5]  A. T. Monroe, S. J. Feigenberg, and N. P. Mendenhall, “Angiosarcoma after breast-conserving therapy,” Cancer, vol. 97, no. 8, pp. 1832–1840, 2003.
[6]  F. Stewart and N. Treves, “Lymphangiosarcoma in post mastectomy lymphedema. A report of six cases in elephantiasis chirurgica,” Cancer, vol. 1, pp. 64–81, 1948.
[7]  S. C. Pendlebury, M. Bilous, and A. O. Langlands, “Sarcomas following radiation therapy for breast cancer: a report of three cases and a review of the literature,” International Journal of Radiation Oncology Biology Physics, vol. 31, no. 2, pp. 405–410, 1995.
[8]  I. Meattini, L. Livi, C. Saieva et al., “Breast cancer following Hodgkin's Disease: the experience of the university of florence,” Breast Journal, vol. 16, no. 3, pp. 290–296, 2010.
[9]  T. Brenn and C. D. Fletcher, “Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopothologic analysis of 42 cases,” American Journal of Surgical Pathology, vol. 29, no. 8, pp. 983–996, 2005.
[10]  N. C. Hodgson, C. Bowen-Wells, F. Moffat, D. Franceschi, and E. Avisar, “Angiosarcomas of the breast: a review of 70 cases,” American Journal of Clinical Oncology, vol. 30, no. 6, pp. 570–573, 2007.
[11]  U. Flucke, L. Requena, and T. Mentzel, “Radiation-induced vascular lesions of the skin: an overview,” Advances in Anatomic Pathology, vol. 20, pp. 407–415, 2013.
[12]  R. Santi, V. Cetica, A. Franchi et al., “Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy,” Histopathology, vol. 58, no. 3, pp. 455–466, 2011.
[13]  T. Mentzel, H. U. Schildhaus, G. Palmedo, R. Büttner, and H. Kutzner, “Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases,” Modern Pathology, vol. 25, no. 1, pp. 75–85, 2012.
[14]  D. M. Parham and C. Fisher, “Angiosarcomas of the breast developing post radiotherapy,” Histopathology, vol. 31, no. 2, pp. 189–195, 1997.
[15]  J. C. Maddox and H. L. Evans, “Angiosarcoma of skin and soft tissue: a study of forty-four cases,” Cancer, vol. 48, no. 8, pp. 1907–1921, 1981.
[16]  M. S. Brady, J. J. Gaynor, and M. F. Brennan, “Radiation-associated sarcoma of bone and soft tissue,” Archives of Surgery, vol. 127, no. 12, pp. 1379–1385, 1992.
[17]  E. A. Morgan, D. E. Kozono, Q. Wang, et al., “Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy,” Annals of Surgical Oncology, vol. 19, pp. 3801–3808, 2012.
[18]  A. T. Monroe, S. J. Feigenberg, and N. P. Mendenhall, “Angiosarcoma after breast-conserving therapy,” Cancer, vol. 97, no. 8, pp. 1832–1840, 2003.
[19]  J. Majeski, R. M. Austin, and R. H. Fitzgerald, “Cutaneous angiosarcoma in an irradiated breast after breast conservation therapy for cancer: association with chronic breast lymphedema,” Journal of Surgical Oncology, vol. 74, no. 3, pp. 208–212, 2000.
[20]  S. D. Billings, J. K. McKenney, A. L. Folpe, M. C. Hardacre, and S. W. Weiss, “Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases,” American Journal of Surgical Pathology, vol. 28, no. 6, pp. 781–788, 2004.
[21]  S. A. Vorburger, Y. Xing, K. K. Hunt et al., “Angiosarcoma of the breast,” Cancer, vol. 104, no. 12, pp. 2682–2688, 2005.
[22]  F. Chahin, A. Paramesh, A. Dwivedi et al., “Angiosarcoma of the breast following breast preservation therapy and local radiation therapy for breast cancer,” Breast Journal, vol. 7, no. 2, pp. 120–123, 2001.
[23]  S. J. Feigenberg, N. Price Mendenhall, J. D. Reith, J. R. Ward, and E. M. Copeland III, “Angiosarcoma after breast-conserving therapy: experience with hyperfractionated radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 52, no. 3, pp. 620–626, 2002.
[24]  G. Hildebrandt, M. Mittag, U. Gütz, M.-L. Kunze, and U.-F. Haustein, “Cutaneous breast angiosarcoma after conserving treatment of breast cancer,” European Journal of Dermatology, vol. 11, no. 6, pp. 580–583, 2001.
[25]  T. D. Mills, S. J. Vinnicombe, C. A. Wells, and R. Carpenter, “Angiosarcoma of the breast after wide local excision and radiotherapy for breast carcinoma,” Clinical Radiology, vol. 57, no. 1, pp. 63–74, 2002.
[26]  C. Polgár, Z. Orosz, A. Szerdahelyi et al., “Postirradiation angiosarcoma of the chest wall and breast: issues of radiogenic origin, diagnosis and treatment in two cases,” Oncology, vol. 60, no. 1, pp. 31–34, 2001.
[27]  S. F. Sener, S. Milos, J. L. Feldman et al., “The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer,” Journal of the American College of Surgeons, vol. 193, no. 1, pp. 22–28, 2001.
[28]  L. J. Solin, A. Fourquet, F. A. Vicini, et al., “Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast,” Cancer, vol. 91, no. 6, pp. 1090–1097, 2001.
[29]  Z. Vesoulis and C. Cunliffe, “Fine-needle aspiration biopsy of postradiation epithelioid angiosarcoma of breast,” Diagnostic Cytopathology, vol. 22, no. 3, pp. 172–175, 2000.
[30]  X. Y. Wang, J. Jakowski, O. W. Tawfik, P. A. Thomas, and F. Fan, “Angiosarcoma of the breast: a clinicopathologic analysis of cases from the last 10 years,” Annals of Diagnostic Pathology, vol. 13, no. 3, pp. 147–150, 2009.
[31]  J. Rao, J. G. DeKoven, J. D. Beatty, and G. Jones, “Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast,” Journal of the American Academy of Dermatology, vol. 49, no. 3, pp. 532–538, 2003.
[32]  L. Esler-Brauer, W. Jaggernauth, and N. C. Zeitouni, “Angiosarcoma developing after conservative treatment for breast carcinoma: case report with review of the current literature,” Dermatologic Surgery, vol. 33, no. 6, pp. 749–755, 2007.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413